Journal profile · Multiple
European Urology Oncology
ISSN 2588-9311 · ELSEVIER · ENGLAND
European Urology Oncology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 7.99; hybrid open access; APC about USD 3,790; median 51 days to acceptance (111 articles, last 24 months); 226 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Urology Oncology is published by ELSEVIER and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research and Bladder and Urothelial Cancer Treatments, together about 54.4% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the European Association of Urology European Urology Oncology is a companion title to European Urology , European Urology Open Science and European Urology Focus , and is the first official publication of the EAU fully devoted to the study of genitourinary malignancies.The journal aims to deliver high quality research while implementing a multi-disciplinary approach to incorporate Urology, Medical Oncology, Radiation Therapy, Imaging, Pathology and Basic Research with the ultimate goal of advancing research in urological oncology.European Urology Oncology includes original articles, opinion piece editorials and invited reviews covering clinical, basic and translational research and is published six times a year in electronic format. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Morgan RouprêtPublisher website
Editorial board by country: none in mainland China; most named United States 58, United Kingdom 16, Italy 16, France 13, Canada 10 (151 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Prostate Cancer Diagnosis and TreatmentMedicine20.8%
- Prostate Cancer Treatment and ResearchMedicine19.6%
- Bladder and Urothelial Cancer TreatmentsMedicine14%
- Renal cell carcinoma treatmentMedicine7%
- Urinary and Genital Oncology StudiesMedicine6.1%
- Cancer Immunotherapy and BiomarkersMedicine2.9%
- Urinary Bladder and Prostate ResearchMedicine2.5%
- Advanced Radiotherapy TechniquesPhysics and Astronomy2.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Urology & Nephrology | Zone 1 |
| Minor | Oncology | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 2 |
| Minor | Urology & Nephrology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
| Minor | Urology & Nephrology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.99LetPub ·
- Impact factor (publisher)
- 8.5Publisher website ·
- CiteScore 2026-06
- 10.7LetPub ·
- CiteScore (publisher)
- 10.7Publisher website ·
- SJR 2026-06
- 3.01LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 78OpenAlex ·
- i10-index
- 627OpenAlex ·
- 2-year mean citedness
- 5.11OpenAlex ·
- Self-citation rate
- 3.5%LetPub ·
- Share of gold OA articles
- 42.07%LetPub ·
Volume
- Articles per year
- 176LetPub ·
Articles by year OpenAlex count · 1,464 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 185 | 81 | 135 |
| 2025 | 226 | 123 | 817 |
| 2024 | 211 | 127 | 2,225 |
| 2023 | 197 | 82 | 3,283 |
| 2022 | 97 | 39 | 2,530 |
| 2021 | 112 | 36 | 3,914 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
51 daysMedian, submission to acceptance · P25–P75 13 days – 127 days
- Acceptance to online
- median 18 days (111 articles)
- Submission to online
- median 76 days
- Sample
- 111 articles with submission and acceptance dates (532 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 24 daysPublisher website ·
- Submission to acceptance
- 71 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,790 / EUR 3,550 / GBP 3,030 / JPY 470,070 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 3,750 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted3, with length limits
- brief reportThese manuscripts report novel, exciting Urological research. The focus may be basic, translation or clinical and can include all aspects of Urological care. Th…Length not stated
- original articleother recognised reporting structures. Original Articles must be no longer than 2750 words, including the abstract but not including the references, tmain text ≤ 2,750 words
- review articleciple solicited by the editorial board. Review Articles must be no longer than 3750 words (250 abstract + 3500 body not including the reference list,main text ≤ 3,750 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review
- AI use The Use of Generative AI and AI-assisted Technologies in Scientific Writing
This policy has been triggered by the rise of generative AI and AI-assisted technologies which are expected to increasingly be used by content creators. The policy aims to provide greater transparency and guidance to authors, readers, reviewers, editors and contributors. Elsevier will monitor this development and will adjust or refine this policy when appropriate. Please note the policy only refer…
Source ↗Publisher website ·- Authorship Authorship Criteria and Authorship Form
Completion and inclusion of the Authorship Responsibility, Financial Disclosure and Acknowledgment Form is an obligatory step of the submission process for Original Articles and Review Articles. A standard disclosure stating conflicts of interests, if any, can be uploaded for letters to the editor, editorials, words of wisdom and case reports. If the form is not completed as instructed below, the …
Source ↗Publisher website ·- Conflicts of interest Declaration of Interest and Financial Disclosures
A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or manuscript.
Source ↗Publisher website ·- Data availability Data Sharing
We expect authors to freeze datasets at the time of publication and to keep copies of this frozen data for up to 5 years. If the dataset continues to increase, we request that authors maintain the copied, frozen original data necessary for publication. We expect that anonymised versions of this dataset are made available upon request from the editorial office, if necessary, for methodological revi…
Source ↗Publisher website ·- Publication ethics Ethical Considerations and Registration of Clinical Trials
Trial Registration: As a member of the International Committee of Medical Journal Editors (ICMJE), European Urology Oncology requires, as a condition of consideration for publication, registration of all trials in a public trials registry that is acceptable to the ICMJE and that requires the minimum registration data set as described by the ICMJE.
Source ↗Publisher website ·- Open access Open Access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer Review Process and Publication
Authors will be sent notifications of the receipt of manuscripts and editorial decisions by e-mail. During the review process, authors can check the status of their submitted manuscript via the online manuscript submission and review system.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- ELSEVIER
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2588-9311
- Society / sponsor
- European Association of Urology European Urology Oncology
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
FAQ
Frequently asked questions about European Urology Oncology
What CAS zone is European Urology Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Urology Oncology is in Zone 1 of Medicine, and in Zone 1 of the minor category Urology & Nephrology / Oncology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Urology Oncology?
The latest impact factor listed by LetPub is 7.99; CiteScore 10.7, h-index 78.
How long does peer review take at European Urology Oncology?
Based on the dates recorded on 111 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 51 days (interquartile range 13–127 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Urology Oncology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 3,750 words; Reference style: AMA; First submission: Free format: the journal's layout is not required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of European Urology Oncology based?
Of the 151 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (58), United Kingdom (16) and Italy (16). Counted from the institutions listed on the board page; for reference only.
Which databases index European Urology Oncology?
According to LetPub and DOAJ records, European Urology Oncology is indexed in SCIE and Scopus.
Is European Urology Oncology open access, and what is the APC?
European Urology Oncology is a hybrid journal. For open-access publication: APC about USD 3,790.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .